Xabier García de Albéniz

RTI Health Solutions, Spain

Poster(s):

• (A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-195) External Control Arm Studies in Marketing Authorisation Applications Submitted to the European Medicines Agency: A Review of Study Design Features and Methods
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-152) Impact of design choices that deviate from a target trial emulation. An application to the estimation of the effect of anticholinergic properties of antidepressants on the incidence of dementia
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-189) Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data (RWD): Challenges and Solutions to Avoid Biases that Generate Immortal Time
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET